These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 29674209)
1. Possible mechanisms underlying fatty liver in a rat model of male hypogonadism: A protective role for testosterone. Sakr HF; Hussein AM; Eid EA; AlKhateeb M Steroids; 2018 Jul; 135():21-30. PubMed ID: 29674209 [TBL] [Abstract][Full Text] [Related]
2. Genistein has beneficial effects on hepatic steatosis in high fat-high sucrose diet-treated rats. Liu H; Zhong H; Yin Y; Jiang Z Biomed Pharmacother; 2017 Jul; 91():964-969. PubMed ID: 28514835 [TBL] [Abstract][Full Text] [Related]
3. Protective Effects of Chaihu Shugan San () on Nonalcoholic Fatty Liver Disease in Rats with Insulin Resistance. Jiang WN; Li D; Jiang T; Guo J; Chen YF; Wang J; Zhou Y; Yang CY; Tang CP Chin J Integr Med; 2018 Feb; 24(2):125-132. PubMed ID: 27164963 [TBL] [Abstract][Full Text] [Related]
4. [Effect of Eletroacupuncture Intervention on Insulin Resistance, Lipid Metabolic Disorder and Expression of Hepatic SREBP-1 c and Fatty Acid Synthase Proteins in Rats with Hyperlipidemia]. Li ZX; Zhang HH; Lan DC; Zhang HT; Chen XZ; Sun J Zhen Ci Yan Jiu; 2018 Jan; 43(1):8-13. PubMed ID: 29383887 [TBL] [Abstract][Full Text] [Related]
5. Resveratrol and fenofibrate ameliorate fructose-induced nonalcoholic steatohepatitis by modulation of genes expression. Abd El-Haleim EA; Bahgat AK; Saleh S World J Gastroenterol; 2016 Mar; 22(10):2931-48. PubMed ID: 26973390 [TBL] [Abstract][Full Text] [Related]
6. The ergogenic supplement β-hydroxy-β-methylbutyrate (HMB) attenuates insulin resistance through suppressing GLUT-2 in rat liver. Sharawy MH; El-Awady MS; Megahed N; Gameil NM Can J Physiol Pharmacol; 2016 May; 94(5):488-97. PubMed ID: 26871756 [TBL] [Abstract][Full Text] [Related]
7. Osthol ameliorates fat milk-induced fatty liver in mice by regulation of hepatic sterol regulatory element-binding protein-1c/2-mediated target gene expression. Du R; Xue J; Wang HB; Zhang Y; Xie ML Eur J Pharmacol; 2011 Sep; 666(1-3):183-8. PubMed ID: 21620823 [TBL] [Abstract][Full Text] [Related]
8. Natural products berberine and curcumin exhibited better ameliorative effects on rats with non-alcohol fatty liver disease than lovastatin. Feng WW; Kuang SY; Tu C; Ma ZJ; Pang JY; Wang YH; Zang QC; Liu TS; Zhao YL; Xiao XH; Wang JB Biomed Pharmacother; 2018 Mar; 99():325-333. PubMed ID: 29353208 [TBL] [Abstract][Full Text] [Related]
9. Paeoniflorin Ameliorates Fructose-Induced Insulin Resistance and Hepatic Steatosis by Activating LKB1/AMPK and AKT Pathways. Li YC; Qiao JY; Wang BY; Bai M; Shen JD; Cheng YX Nutrients; 2018 Aug; 10(8):. PubMed ID: 30081580 [TBL] [Abstract][Full Text] [Related]
10. Kukoamine A attenuates insulin resistance and fatty liver through downregulation of Srebp-1c. Li G; Zhou F; Chen Y; Zhang W; Wang N Biomed Pharmacother; 2017 May; 89():536-543. PubMed ID: 28254666 [TBL] [Abstract][Full Text] [Related]
11. [Effect of Fuzi Lizhong decoction in reducing liver injury of rats with non-alcoholic fatty liver via activating AMPK and suppressing NF-κBp65 pathway]. Yang JY; Shi ZH; Ma W; Tao DQ; Liu S; Chen L; Zhou XL Zhongguo Zhong Yao Za Zhi; 2018 Aug; 43(15):3176-3183. PubMed ID: 30200715 [TBL] [Abstract][Full Text] [Related]
12. Modulation of hepatic sterol regulatory element-binding protein-1c-mediated gene expression contributes to Salacia oblonga root-elicited improvement of fructose-induced fatty liver in rats. Liu L; Yang M; Lin X; Li Y; Liu C; Yang Y; Yamahara J; Wang J; Li Y J Ethnopharmacol; 2013 Dec; 150(3):1045-52. PubMed ID: 24157375 [TBL] [Abstract][Full Text] [Related]
13. Acylated ghrelin induces but deacylated ghrelin prevents hepatic steatosis and insulin resistance in lean rats: Effects on DAG/ PKC/JNK pathway. Dallak MA Biomed Pharmacother; 2018 Sep; 105():299-311. PubMed ID: 29860222 [TBL] [Abstract][Full Text] [Related]
14. Treatment with PPARδ agonist alleviates non-alcoholic fatty liver disease by modulating glucose and fatty acid metabolic enzymes in a rat model. Li X; Li J; Lu X; Ma H; Shi H; Li H; Xie D; Dong L; Liang C Int J Mol Med; 2015 Sep; 36(3):767-75. PubMed ID: 26133486 [TBL] [Abstract][Full Text] [Related]
15. Obestatin protects and reverses nonalcoholic fatty liver disease and its associated insulin resistance in rats via inhibition of food intake, enhancing hepatic adiponectin signaling, and blocking ghrelin acylation. Khaleel EF; Abdel-Aleem GA Arch Physiol Biochem; 2019 Feb; 125(1):64-78. PubMed ID: 29429367 [TBL] [Abstract][Full Text] [Related]
16. Prevention and treatment effect of total flavonoids in Stellera chamaejasme L. on nonalcoholic fatty liver in rats. Wang Y; Li JY; Han M; Wang WL; Li YZ Lipids Health Dis; 2015 Aug; 14():85. PubMed ID: 26242978 [TBL] [Abstract][Full Text] [Related]
17. Ameliorative effects of lutein on non-alcoholic fatty liver disease in rats. Qiu X; Gao DH; Xiang X; Xiong YF; Zhu TS; Liu LG; Sun XF; Hao LP World J Gastroenterol; 2015 Jul; 21(26):8061-72. PubMed ID: 26185377 [TBL] [Abstract][Full Text] [Related]
18. Enhancement in liver SREBP-1c/PPAR-alpha ratio and steatosis in obese patients: correlations with insulin resistance and n-3 long-chain polyunsaturated fatty acid depletion. Pettinelli P; Del Pozo T; Araya J; Rodrigo R; Araya AV; Smok G; Csendes A; Gutierrez L; Rojas J; Korn O; Maluenda F; Diaz JC; Rencoret G; Braghetto I; Castillo J; Poniachik J; Videla LA Biochim Biophys Acta; 2009 Nov; 1792(11):1080-6. PubMed ID: 19733654 [TBL] [Abstract][Full Text] [Related]
19. Oxymatrine ameliorates non-alcoholic fatty liver disease in rats through peroxisome proliferator-activated receptor-α activation. Shi L; Shi L; Zhang H; Hu Z; Wang C; Zhang D; Song G Mol Med Rep; 2013 Aug; 8(2):439-45. PubMed ID: 23754536 [TBL] [Abstract][Full Text] [Related]
20. [Effects of soothing liver and invigorating spleen recipes on SREBP-1c, SCD-1 mRNA and proteins expression in hepatocytes of NAFLD rats]. Xu YJ; Yang QH; Han L; Zhang YP; Liu YZ; Jin L; Yan HZ Zhong Yao Cai; 2014 Jan; 37(1):80-6. PubMed ID: 25090711 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]